↓ Skip to main content

Simvastatin inhibits planktonic cells and biofilms of Candida and Cryptococcus species

Overview of attention for article published in Brazilian Journal of Infectious Diseases, June 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#32 of 809)
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
55 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Simvastatin inhibits planktonic cells and biofilms of Candida and Cryptococcus species
Published in
Brazilian Journal of Infectious Diseases, June 2015
DOI 10.1016/j.bjid.2015.06.001
Pubmed ID
Authors

Raimunda Sâmia Nogueira Brilhante, Erica Pacheco Caetano, Jonathas Sales de Oliveira, Débora de Souza Collares Maia Castelo-Branco, Elizabeth Ribeiro Yokobatake Souza, Lucas Pereira de Alencar, Rossana de Aguiar Cordeiro, Tereza de Jesus Pinheiro Gomes Bandeira, José Júlio Costa Sidrim, Marcos Fábio Gadelha Rocha

Abstract

The antifungal activity of some statins against different fungal species has been reported. Thus, at the first moment, the in vitro antifungal activity of simvastatin, atorvastatin and pravastatin was tested against Candida spp. and Cryptococcus spp. Then, in a second approach, considering that the best results were obtained for simvastatin, this drug was evaluated in combination with antifungal drugs against planktonic growth and tested against biofilms of Candida spp. and Cryptococcus spp. Drug susceptibility testing was performed using the microdilution broth method, as described by the Clinical and Laboratory Standards Institute. The interaction between simvastatin and antifungals against planktonic cells was analyzed by calculating the fractional inhibitory concentration index. Regarding biofilm susceptibility, simvastatin was tested against growing biofilm and mature biofilm of one strain of each tested yeast species. Simvastatin showed inhibitory effect against Candida spp. and Cryptococcus spp. with minimum inhibitory concentration values ranging from 15.6 to 1000mgL(-1) and from 62.5 to 1000mgL(-1), respectively. The combination of simvastatin with itraconazole and fluconazole showed synergism against Candida spp. and Cryptococcus spp., while the combination of simvastatin with amphotericin B was synergistic only against Cryptococcus spp. Concerning the biofilm assays, simvastatin was able to inhibit both growing biofilm and mature biofilm of Candida spp. and Cryptococcus spp. The present study showed that simvastatin inhibits planktonic cells and biofilms of Candida and Cryptococcus species.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 2%
Brazil 1 2%
Unknown 53 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 22%
Student > Bachelor 6 11%
Student > Postgraduate 5 9%
Lecturer 3 5%
Lecturer > Senior Lecturer 2 4%
Other 8 15%
Unknown 19 35%
Readers by discipline Count As %
Immunology and Microbiology 7 13%
Medicine and Dentistry 7 13%
Agricultural and Biological Sciences 7 13%
Biochemistry, Genetics and Molecular Biology 3 5%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Other 5 9%
Unknown 23 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 December 2015.
All research outputs
#2,759,728
of 25,373,627 outputs
Outputs from Brazilian Journal of Infectious Diseases
#32
of 809 outputs
Outputs of similar age
#33,986
of 278,169 outputs
Outputs of similar age from Brazilian Journal of Infectious Diseases
#1
of 22 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 809 research outputs from this source. They receive a mean Attention Score of 3.4. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 278,169 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.